You are here

Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection

Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection
Published: 
Mar 2016
Publisher: 
PLoS Pathog.
Author: 
Jason Smith, Ph.D.

Gounder AP1, Myers ND1, Treuting PM2, Bromme BA1, Wilson SS1, Wiens ME1, Lu W3, Ouellette AJ4, Spindler KR5, Parks WC6, Smith JG1.

Author information

  • 1Department of Microbiology, University of Washington, Seattle, Washington, United States of America.
  • 2Department of Comparative Medicine, University of Washington, Seattle, Washington, United States of America.
  • 3Institute of Human Virology and Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
  • 4Department of Pathology and Laboratory Medicine, Keck School of Medicine of the University of Southern California, USC Norris Cancer Center, Los Angeles, California, United States of America.
  • 5Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.
  • 6Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.

Abstract

α-defensins are abundant antimicrobial peptides with broad, potent antibacterial, antifungal, and antiviral activities in vitro. Although their contribution to host defense against bacteria in vivo has been demonstrated, comparable studies of their antiviral activity in vivo are lacking. Using a mouse model deficient in activated α-defensins in the small intestine, we show that Paneth cell α-defensins protect mice from oral infection by a pathogenic virus, mouse adenovirus 1 (MAdV-1). Survival differences between mouse genotypes are lost upon parenteral MAdV-1 infection, strongly implicating a role for intestinal defenses in attenuating pathogenesis. Although differences in α-defensin expression impact the composition of the ileal commensal bacterial population, depletion studies using broad-spectrum antibiotics revealed no effect of the microbiota on α-defensin-dependent viral pathogenesis. Moreover, despite the sensitivity of MAdV-1 infection to α-defensin neutralization in cell culture, we observed no barrier effect due to Paneth cell α-defensin activation on the kinetics and magnitude of MAdV-1 dissemination to the brain. Rather, a protective neutralizing antibody response was delayed in the absence of α-defensins. This effect was specific to oral viral infection, because antibody responses to parenteral or mucosal ovalbumin exposure were not affected by α-defensin deficiency. Thus, α-defensins play an important role as adjuvants in antiviral immunity in vivo that is distinct from their direct antiviral activity observed in cell culture.